This one looks interesting. AHS-A. ~9.5 mil shares out. Trading @ .38. Chart shows recent move upward with volume.
HEPATICO & HEPATITIS
RICHMOND, B.C., May 21 /CNW/ - ALTA Natural Herbs & Supplements Ltd. (The
''Corporation'') announces it will begin immediate testing of HEPATICO with
100 Hepatitis sufferers. The Corporation has manufactured 12,000 capsules of
HEPATICO in its first production run for this on May 20, 1998 as per the
technical specifications provided by its Georgian partner. The initial lot is
available without charge on condition the patients' physicians will assist
them with their decision to use HEPATICO and supervise and monitor changes in
their condition over the period they are consuming the herbal remedy, and
record and report back all results to the Corporation's physicians.
Alta Natural Herbs & Supplements Ltd. and the RA Co. Ltd., Tbilisi,
Republic of Georgia, are structuring a joint venture company in North America
to manufacture and market HEPATICO, a traditional herbal remedy from the
Mingrolian and Zemo-svanetian mountain region in the Republic of Georgia. It
has been researched and prescribed since 1992 by the medical communities of
Eastern Europe for patients with acute forms of hepatitis A, B, and C, and
cirrhosis of the liver with a high success rate.
In the Georgian and Russian trials, patients, adults and children treated
with HEPATICO showed significant healing in 7 to 10 days and 14 to 28 days for
those suffering from acute and chronic hepatitis, respectively. Of 300
cirrhosis of the liver patients, there was a 91 % success rate with healing
and restoration of all organs medically confirmed in 273 cases.
The Corporation hopes to duplicate these results which should help gain
recognition and acceptance for this treatment in North America, and worldwide.
Hepatitis has become a serious medical crisis and there has been no known cure
for this deadly disease. Preclinical and clinical studies of HEPATICO
completed in the Republic of Georgia and Russia have shown to be highly
successful in treating toxic and infectious hepatitis, and cirrhosis of the
liver.
Adolf Huckschlag, President (signed)
---------------------------------
The Alberta Stock Exchange has neither approved or disapproved the
information contained herein.
-30- |
